Replies to post #41907 on SiNtx Technologies Inc (SINT)

[boston745]

Its definitely to help increase stock price, signals a change by management (finally), possibly help sell why employee stock plan passes this time when it didnt last year. Regardless, thats not fluff. They have possible cash influxes coming from sell of armor assets and if they sell off their industrial business with other potentials if their partners step up. They cut their burn to about $1-1.5m a quarter so that helps stretch their current cash on hand and makes it easier to get to cash positive with any new medical/Antipathogenic products coming to market. Still they'll look foolish doing this and then raising next year at low prices. I doubt that due to the fact that Lind updated its 13/G, oddly after 9 months, and half its warrants expire in August at $50. Buying back shares appears like maneuvers to bring about 50+ given the timing of all this. Thats only if these various things are all connected.

========================================

Here is a collection of my research going over multiple subjects including Sintx connections with Zimmer Biomet, Solventum, Morgan Ceramics, & NP Aerospace. Includes other research topics as well.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175357996

========================================

Section 3 - Silicon Nitride, a Close to Ideal Ceramic Material for Medical Application

examples of their medical applications that relate to spinal, orthopedic and dental implants, bone grafts and scaffolds, platforms for intelligent synthetic neural circuits, antibacterial and antiviral particles and coatings, optical biosensors, and nano-photonic waveguides for sophisticated medical diagnostic devices are all covered in the research reviewed herein. The examples provided convincingly show that silicon nitride is destined to become a leader to replace titanium and other entrenched biomaterials in many fields of medicine.

https://www.mdpi.com/2571-6131/4/2/16/htm